Barr, Kos Pharma In Talks To Settle Niaspan Patent Litigation

Law360, New York (March 30, 2005, 12:00 AM EST) -- Barr Pharmaceuticals Inc. and Kos Pharmaceuticals Inc. are in talks to settle their outstanding patent litigation regarding Kos' cholesterol reducing drug Niaspan, the two companies said Wednesday.

The case is currently before the U.S. District Court for the Southern District of New York. A trial is tentatively scheduled to begin in February 2006.

The companies said they expect the court to discontinue and stay all proceedings to allow the parties to negotiate a definitive settlement agreement.

The companies will have the right to have the matter...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.